Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Azithromycin or metronidazole for elevated procalcitonin in chronic heart failure
2011-004745-40Phase 4Completed
- Sponsor
- Hull University Teaching Hospitals
- Start
- Feb 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of azithromycin and metronidazole in chronic heart failure (CHF) (3 arms), sponsored by Hull University Teaching Hospitals. Started Feb 2012; status: completed.
02
Drugs
azithromycinmetronidazole
03
Conditions
chronic heart failure (CHF)
Beyond the preview
Go deeper on 2011-004745-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-004745-40.